To investigate the effect of the synthetic CB1 cannabinoids on E- and N-cadherin expressions in pancreatic PANC-1 cancer cells, we first investigated the presence of E-cadherin following treatment, similarly to the SW-620 cells. The gene discussed is CDH2; the disease is cancer.